RECRUITING

Ultrasound Guided Radiofrequency Ablation of the Occipital Nerve

Talk to us

Conditions

Nerve Pain

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Study an ultrasound guided approach to radiofrequency ablation of the occipital nerve that makes it possible to see the needle during treatment procedure. It is hoped this will reduce the amount of pain after the standard of care procedure.

Official Title

Ultrasound Guided Radiofrequency Ablation of the Occipital Nerve

Quick Facts

Study Start:2022-07-01
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06583122

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients between the ages of 18-80 with a diagnosis of occipital neuralgia or migraine overlying the occipital region.
  2. * A diagnosis of occipital neuralgia will be based on the International Classification of Headache Disorders (ICHD), whose criteria include: paroxysmal stabbing pain in the distribution of the GON, tenderness over the affected nerve, and relief of pain for at least 3 hours after bupivacaine local anesthetic block of the affected nerve.
  3. * Patients may also be included if they have a diagnosis of migraine based on the ICHD criteria with predominance of pain over the occipital region that responded to occipital nerve block.
  4. * Patients must have failed oral medications including NSAIDs, opioids, and anticonvulsants for the management of their pain.
  5. * Failed treatment will be \<50% pain reduction with oral medication.
  6. * Patients must report headache frequency of at least 10 days per month.
  1. * Patients will be excluded from the trial if they have an unstable medical or psychological condition,
  2. * are pregnant,
  3. * have an implanted cardiac pacemaker or defibrillator that could not be disabled,
  4. * have had a craniotomy or scar tissue overlying the site from a previous surgery,
  5. * have a history of cervical spine fusion,
  6. * have evidence of elevated ICP or intracranial tumor,
  7. * or have previous RFA treatment of the greater or lesser occipital nerve.

Contacts and Locations

Study Contact

Timothy Sowder, MD
CONTACT
913-588-6670
tsowder@kumc.edu
Manuel Clark
CONTACT
913-945-5763
mclark16@kumc.edu

Study Locations (Sites)

University of Kansas Medical Center
Kansas City, Kansas, 66160
United States

Collaborators and Investigators

Sponsor: University of Kansas Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-01
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2022-07-01
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Nerve Pain